GDC-0994 (Ravoxertinib)

SKU: C-1150-5mg

Quantity (mg):

5 mg

Product Options

Quantity

$91.99

Catalog#: C-1150

Targets: ERK

Synonym: GDC0994; GDC-0994; GDC 0994; RG7842; RG-7842; RG 7842; Ravoxertinib

Chemical Name/IUPAC:(S)-1-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one

Technical Data

Product Name: GDC-0994 (Ravoxertinib)

Chemical Formula: C21H18ClFN6O2

Molecular Weight: 440.86

CAS#: 1453848-26-4

Appearance: Solid powder

Purity: > 99% by HPLC

Solubility: Soluble in DMSO

Storage: Room temperature for months, or -20ºC for 3 years

Description
GDC-0994 (Ravoxertinib) is an orally available inhibitor of extracellular signal-regulated kinase (ERK), with potential antineoplastic activity. Upon oral administration, GDC-0994 inhibits both ERK phosphorylation and activation of ERK-mediated signal transduction pathways. This prevents ERK-dependent tumor cell proliferation and survival. The mitogen-activated protein kinase (MAPK)/ERK pathway is upregulated in a variety of tumor cell types and plays a key role in tumor cell proliferation, differentiation and survival.

GDC-0994 (Ravoxertinib)

Related products

BMS-906024

ABT-263 (Navitoclax)

MEK-162 (ARRY-162)

E-7090